Serial Number | 98238182 |
Word Mark | CADENT |
Filing Date | Tuesday, October 24, 2023 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Monday, October 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 19, 2024 |
Goods and Services | Providing medical services in the field of ear, nose, and throat; surgery in the field of ear, nose, and throat; facial plastic surgery; allergy care, namely, the testing, diagnosis, medical advice and administration of treatments for allergic conditions; and audiology services, namely, the testing, diagnosis, medical advice, and administration of treatments, services, medical and/or surgical interventions, and devices to treat hearing loss |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 31, 2023 |
Primary Code | 044 |
First Use Anywhere Date | Tuesday, November 28, 2017 |
First Use In Commerce Date | Tuesday, November 28, 2017 |
Party Name | ENT Specialty Partners MSO, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Irving, TX 75038 |
Event Date | Event Description |
Friday, October 27, 2023 | NEW APPLICATION ENTERED |
Tuesday, October 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, June 13, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, September 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, June 7, 2024 | ASSIGNED TO EXAMINER |
Thursday, June 13, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, June 13, 2024 | NON-FINAL ACTION WRITTEN |
Friday, September 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, October 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, September 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |